XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 175 filers reported holding XENON PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $375,760 | -11.3% | 11,000 | 0.0% | 0.14% | -7.2% |
Q2 2023 | $423,500 | +7.6% | 11,000 | 0.0% | 0.15% | -1.3% |
Q1 2023 | $393,690 | -9.2% | 11,000 | 0.0% | 0.15% | -14.4% |
Q4 2022 | $433,730 | +9.3% | 11,000 | 0.0% | 0.18% | +4.0% |
Q3 2022 | $397,000 | +18.5% | 11,000 | 0.0% | 0.17% | +29.1% |
Q2 2022 | $335,000 | -0.3% | 11,000 | 0.0% | 0.13% | +21.8% |
Q1 2022 | $336,000 | -2.3% | 11,000 | 0.0% | 0.11% | +4.8% |
Q4 2021 | $344,000 | +104.8% | 11,000 | 0.0% | 0.10% | +90.9% |
Q3 2021 | $168,000 | -18.0% | 11,000 | 0.0% | 0.06% | -16.7% |
Q2 2021 | $205,000 | +4.1% | 11,000 | 0.0% | 0.07% | -2.9% |
Q1 2021 | $197,000 | +16.6% | 11,000 | 0.0% | 0.07% | +7.9% |
Q4 2020 | $169,000 | +38.5% | 11,000 | 0.0% | 0.06% | +23.5% |
Q3 2020 | $122,000 | -11.6% | 11,000 | 0.0% | 0.05% | -19.0% |
Q2 2020 | $138,000 | +10.4% | 11,000 | 0.0% | 0.06% | -8.7% |
Q1 2020 | $125,000 | -13.2% | 11,000 | 0.0% | 0.07% | +15.0% |
Q4 2019 | $144,000 | +45.5% | 11,000 | 0.0% | 0.06% | +33.3% |
Q3 2019 | $99,000 | – | 11,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |